glp-1 and mcas GLP-1s in with Dr. Tania Dempsey - Mast Cell Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast Not all GLP-1s work the

Their growing presence in healthcare invites ongoing dialogue about how best to support longterm wellness in our communities

The combination product Xultophy contains both insulin degludec (Tresiba) and liraglutide (a GLP-1) in a single injection

51 Addressing these adverse effects is crucial for improving patient compliance and therapeutic outcomes

Nutritional changes: Reduced appetite can lead to lower intake of calcium, vitamin D, and other nutrients essential for tooth and bone health

Fatigue or dizziness Some patients feel a bit tired or lightheaded, especially if they're eating far fewer calories

Researchers are examining its known ability to improve the way we help people who face chronic weight management